Correlations between ATF3 polymorphisms and ischemic stroke in Dali, Yunnan Province, as determined by a case-control study

Genetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the association between ATF3 polymorphisms and susceptibility to IS remains unclear. Therefore, we aimed to explore the association between ATF3 single-nuc...

Full description

Saved in:
Bibliographic Details
Published inBMC neurology Vol. 25; no. 1; pp. 216 - 11
Main Authors Yang, Yunhui, Wang, Pengyu, Wang, Min, Wang, Guangming
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 21.05.2025
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Genetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the association between ATF3 polymorphisms and susceptibility to IS remains unclear. Therefore, we aimed to explore the association between ATF3 single-nucleotide polymorphisms (SNPs) and genetic susceptibility to IS in a population in Dali, Yunnan, China. We included 145 patients with IS and 127 healthy controls in this case-control study. ATF3 SNP sites (rs1105899, rs1008737, rs1195474, and rs1195472) were genotyped using SNaPshot detection. Venous serum glucose (VSG), white blood cell count, total cholesterol, triglycerides, low-density lipoprotein cholesterol, and systolic blood pressure (SBP) were IS risk factors; VSG had the highest impact on IS susceptibility, whereas SBP had the lowest. Genotype distributions of rs1105899, rs1008737, and rs1195472 polymorphisms in the control group conformed to the Hardy-Weinberg equilibrium. Association analysis between ATF3 polymorphisms and IS risk showed that rs1105899, rs1008737, and rs1195474 ATF3 polymorphisms were not significantly associated with IS risk. In the codominant and superdominant model of the rs1195472 [C/T] loci, CT genotype can reduce the risk of stroke, compared with TT and CC genotypes. Haplotype AGAC was an inhibitory factor for IS. The GTEx database showed that the rs1195472 CT genotype increased ATF3 expression and was associated with its expression in individual tissues. The rs1195472 polymorphism was associated with IS risk in our study population; no significant correlation was noted between rs1105899, rs1008737, and rs1195474 polymorphisms and IS.
AbstractList BackgroundGenetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the association between ATF3 polymorphisms and susceptibility to IS remains unclear. Therefore, we aimed to explore the association between ATF3 single-nucleotide polymorphisms (SNPs) and genetic susceptibility to IS in a population in Dali, Yunnan, China.MethodsWe included 145 patients with IS and 127 healthy controls in this case-control study. ATF3 SNP sites (rs1105899, rs1008737, rs1195474, and rs1195472) were genotyped using SNaPshot detection.ResultsVenous serum glucose (VSG), white blood cell count, total cholesterol, triglycerides, low-density lipoprotein cholesterol, and systolic blood pressure (SBP) were IS risk factors; VSG had the highest impact on IS susceptibility, whereas SBP had the lowest. Genotype distributions of rs1105899, rs1008737, and rs1195472 polymorphisms in the control group conformed to the Hardy–Weinberg equilibrium. Association analysis between ATF3 polymorphisms and IS risk showed that rs1105899, rs1008737, and rs1195474 ATF3 polymorphisms were not significantly associated with IS risk. In the codominant and superdominant model of the rs1195472 [C/T] loci, CT genotype can reduce the risk of stroke, compared with TT and CC genotypes. Haplotype AGAC was an inhibitory factor for IS. The GTEx database showed that the rs1195472 CT genotype increased ATF3 expression and was associated with its expression in individual tissues.ConclusionThe rs1195472 polymorphism was associated with IS risk in our study population; no significant correlation was noted between rs1105899, rs1008737, and rs1195474 polymorphisms and IS.
Genetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the association between ATF3 polymorphisms and susceptibility to IS remains unclear. Therefore, we aimed to explore the association between ATF3 single-nucleotide polymorphisms (SNPs) and genetic susceptibility to IS in a population in Dali, Yunnan, China. We included 145 patients with IS and 127 healthy controls in this case-control study. ATF3 SNP sites (rs1105899, rs1008737, rs1195474, and rs1195472) were genotyped using SNaPshot detection. Venous serum glucose (VSG), white blood cell count, total cholesterol, triglycerides, low-density lipoprotein cholesterol, and systolic blood pressure (SBP) were IS risk factors; VSG had the highest impact on IS susceptibility, whereas SBP had the lowest. Genotype distributions of rs1105899, rs1008737, and rs1195472 polymorphisms in the control group conformed to the Hardy-Weinberg equilibrium. Association analysis between ATF3 polymorphisms and IS risk showed that rs1105899, rs1008737, and rs1195474 ATF3 polymorphisms were not significantly associated with IS risk. In the codominant and superdominant model of the rs1195472 [C/T] loci, CT genotype can reduce the risk of stroke, compared with TT and CC genotypes. Haplotype AGAC was an inhibitory factor for IS. The GTEx database showed that the rs1195472 CT genotype increased ATF3 expression and was associated with its expression in individual tissues. The rs1195472 polymorphism was associated with IS risk in our study population; no significant correlation was noted between rs1105899, rs1008737, and rs1195474 polymorphisms and IS.
Genetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the association between ATF3 polymorphisms and susceptibility to IS remains unclear. Therefore, we aimed to explore the association between ATF3 single-nucleotide polymorphisms (SNPs) and genetic susceptibility to IS in a population in Dali, Yunnan, China.BACKGROUNDGenetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the association between ATF3 polymorphisms and susceptibility to IS remains unclear. Therefore, we aimed to explore the association between ATF3 single-nucleotide polymorphisms (SNPs) and genetic susceptibility to IS in a population in Dali, Yunnan, China.We included 145 patients with IS and 127 healthy controls in this case-control study. ATF3 SNP sites (rs1105899, rs1008737, rs1195474, and rs1195472) were genotyped using SNaPshot detection.METHODSWe included 145 patients with IS and 127 healthy controls in this case-control study. ATF3 SNP sites (rs1105899, rs1008737, rs1195474, and rs1195472) were genotyped using SNaPshot detection.Venous serum glucose (VSG), white blood cell count, total cholesterol, triglycerides, low-density lipoprotein cholesterol, and systolic blood pressure (SBP) were IS risk factors; VSG had the highest impact on IS susceptibility, whereas SBP had the lowest. Genotype distributions of rs1105899, rs1008737, and rs1195472 polymorphisms in the control group conformed to the Hardy-Weinberg equilibrium. Association analysis between ATF3 polymorphisms and IS risk showed that rs1105899, rs1008737, and rs1195474 ATF3 polymorphisms were not significantly associated with IS risk. In the codominant and superdominant model of the rs1195472 [C/T] loci, CT genotype can reduce the risk of stroke, compared with TT and CC genotypes. Haplotype AGAC was an inhibitory factor for IS. The GTEx database showed that the rs1195472 CT genotype increased ATF3 expression and was associated with its expression in individual tissues.RESULTSVenous serum glucose (VSG), white blood cell count, total cholesterol, triglycerides, low-density lipoprotein cholesterol, and systolic blood pressure (SBP) were IS risk factors; VSG had the highest impact on IS susceptibility, whereas SBP had the lowest. Genotype distributions of rs1105899, rs1008737, and rs1195472 polymorphisms in the control group conformed to the Hardy-Weinberg equilibrium. Association analysis between ATF3 polymorphisms and IS risk showed that rs1105899, rs1008737, and rs1195474 ATF3 polymorphisms were not significantly associated with IS risk. In the codominant and superdominant model of the rs1195472 [C/T] loci, CT genotype can reduce the risk of stroke, compared with TT and CC genotypes. Haplotype AGAC was an inhibitory factor for IS. The GTEx database showed that the rs1195472 CT genotype increased ATF3 expression and was associated with its expression in individual tissues.The rs1195472 polymorphism was associated with IS risk in our study population; no significant correlation was noted between rs1105899, rs1008737, and rs1195474 polymorphisms and IS.CONCLUSIONThe rs1195472 polymorphism was associated with IS risk in our study population; no significant correlation was noted between rs1105899, rs1008737, and rs1195474 polymorphisms and IS.
Abstract Background Genetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the association between ATF3 polymorphisms and susceptibility to IS remains unclear. Therefore, we aimed to explore the association between ATF3 single-nucleotide polymorphisms (SNPs) and genetic susceptibility to IS in a population in Dali, Yunnan, China. Methods We included 145 patients with IS and 127 healthy controls in this case-control study. ATF3 SNP sites (rs1105899, rs1008737, rs1195474, and rs1195472) were genotyped using SNaPshot detection. Results Venous serum glucose (VSG), white blood cell count, total cholesterol, triglycerides, low-density lipoprotein cholesterol, and systolic blood pressure (SBP) were IS risk factors; VSG had the highest impact on IS susceptibility, whereas SBP had the lowest. Genotype distributions of rs1105899, rs1008737, and rs1195472 polymorphisms in the control group conformed to the Hardy–Weinberg equilibrium. Association analysis between ATF3 polymorphisms and IS risk showed that rs1105899, rs1008737, and rs1195474 ATF3 polymorphisms were not significantly associated with IS risk. In the codominant and superdominant model of the rs1195472 [C/T] loci, CT genotype can reduce the risk of stroke, compared with TT and CC genotypes. Haplotype AGAC was an inhibitory factor for IS. The GTEx database showed that the rs1195472 CT genotype increased ATF3 expression and was associated with its expression in individual tissues. Conclusion The rs1195472 polymorphism was associated with IS risk in our study population; no significant correlation was noted between rs1105899, rs1008737, and rs1195474 polymorphisms and IS.
Background Genetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the association between ATF3 polymorphisms and susceptibility to IS remains unclear. Therefore, we aimed to explore the association between ATF3 single-nucleotide polymorphisms (SNPs) and genetic susceptibility to IS in a population in Dali, Yunnan, China. Methods We included 145 patients with IS and 127 healthy controls in this case-control study. ATF3 SNP sites (rs1105899, rs1008737, rs1195474, and rs1195472) were genotyped using SNaPshot detection. Results Venous serum glucose (VSG), white blood cell count, total cholesterol, triglycerides, low-density lipoprotein cholesterol, and systolic blood pressure (SBP) were IS risk factors; VSG had the highest impact on IS susceptibility, whereas SBP had the lowest. Genotype distributions of rs1105899, rs1008737, and rs1195472 polymorphisms in the control group conformed to the Hardy-Weinberg equilibrium. Association analysis between ATF3 polymorphisms and IS risk showed that rs1105899, rs1008737, and rs1195474 ATF3 polymorphisms were not significantly associated with IS risk. In the codominant and superdominant model of the rs1195472 [C/T] loci, CT genotype can reduce the risk of stroke, compared with TT and CC genotypes. Haplotype AGAC was an inhibitory factor for IS. The GTEx database showed that the rs1195472 CT genotype increased ATF3 expression and was associated with its expression in individual tissues. Conclusion The rs1195472 polymorphism was associated with IS risk in our study population; no significant correlation was noted between rs1105899, rs1008737, and rs1195474 polymorphisms and IS. Keywords: ATF3, Ischemic stroke, Genetic susceptibility, Single-nucleotide polymorphisms
Genetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the association between ATF3 polymorphisms and susceptibility to IS remains unclear. Therefore, we aimed to explore the association between ATF3 single-nucleotide polymorphisms (SNPs) and genetic susceptibility to IS in a population in Dali, Yunnan, China. We included 145 patients with IS and 127 healthy controls in this case-control study. ATF3 SNP sites (rs1105899, rs1008737, rs1195474, and rs1195472) were genotyped using SNaPshot detection. Venous serum glucose (VSG), white blood cell count, total cholesterol, triglycerides, low-density lipoprotein cholesterol, and systolic blood pressure (SBP) were IS risk factors; VSG had the highest impact on IS susceptibility, whereas SBP had the lowest. Genotype distributions of rs1105899, rs1008737, and rs1195472 polymorphisms in the control group conformed to the Hardy-Weinberg equilibrium. Association analysis between ATF3 polymorphisms and IS risk showed that rs1105899, rs1008737, and rs1195474 ATF3 polymorphisms were not significantly associated with IS risk. In the codominant and superdominant model of the rs1195472 [C/T] loci, CT genotype can reduce the risk of stroke, compared with TT and CC genotypes. Haplotype AGAC was an inhibitory factor for IS. The GTEx database showed that the rs1195472 CT genotype increased ATF3 expression and was associated with its expression in individual tissues. The rs1195472 polymorphism was associated with IS risk in our study population; no significant correlation was noted between rs1105899, rs1008737, and rs1195474 polymorphisms and IS.
ArticleNumber 216
Audience Academic
Author Wang, Guangming
Wang, Min
Wang, Pengyu
Yang, Yunhui
Author_xml – sequence: 1
  givenname: Yunhui
  orcidid: 0000-0002-2550-3822
  surname: Yang
  fullname: Yang, Yunhui
– sequence: 2
  givenname: Pengyu
  orcidid: 0000-0002-6336-7673
  surname: Wang
  fullname: Wang, Pengyu
– sequence: 3
  givenname: Min
  orcidid: 0009-0001-7528-1156
  surname: Wang
  fullname: Wang, Min
– sequence: 4
  givenname: Guangming
  orcidid: 0000-0002-0220-1493
  surname: Wang
  fullname: Wang, Guangming
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40399867$$D View this record in MEDLINE/PubMed
BookMark eNptkk9vFCEYhyemxv7RL-DBkHjx0KkwwAAns1mtNmmih3rwRBh4Z5c6AyvM1mz98rLdWrvGcIC8PDzkhd9xdRBigKp6SfAZIbJ9m0kjJa1xw2vMGsrr2yfVEWGC1A0V4uDR-rA6zvkaYyIkI8-qQ4apUrIVR9WveUwJBjP5GDLqYPoJENDs6pyiVRw2Y0yrpc9jRiY45LNdwugtylOK3wH5gN6bwZ-ib-sQTEBfUrzxwcIpMhk5mCCNPoBD3QYZZE2G2sZQjg5FsHab59XT3gwZXtzPJ9XX8w9X80_15eePF_PZZW05EVOtbK-cUQxbjhvMRUMoVT3jnHeKOtPajvdKCNFA76RqedcD6wlhuFVtJxpHT6qLnddFc61XyY8mbXQ0Xt8VYlpokyZvB9CEM2uZKv6uZ8CMktIa6CTpJDPEseJ6t3Ot1t0IzkLpxwx70v2d4Jd6EW80abBqhSDF8ObekOKPNeRJj-VdYRhMgLjOmja45YqQVhT09T_odVynUN6qUKTlXKlW_qUWpnTgQx_LxXYr1TPJsBQU07ZQZ_-hynDbHy3B6n2p7x149bjThxb_ZKcAzQ6wKeacoH9ACNbbgOpdQHUJqL4LqL6lvwGP09et
Cites_doi 10.1016/S2468-2667(21)00228-0
10.1007/s12035-014-8710-0
10.1007/s12975-022-01121-5
10.1212/CON.0000000000000416
10.1007/s00109-022-02263-7
10.1016/j.nbd.2005.06.002
10.1016/S1474-4422(04)00708-2
10.1006/mcne.1999.0814
10.1177/17474930221135983
10.1016/j.cca.2011.02.011
10.1073/pnas.1821979116
10.1016/j.neuroscience.2012.06.010
10.1016/j.juro.2008.07.066
10.1530/EJE-07-0793
10.3390/ijms21186454
10.1128/MCB.24.13.5721-5732.2004
10.1016/S0378-1119(01)00551-0
10.1016/S1474-4422(18)30500-3
10.1097/MD.0000000000007564
10.3390/genes13010048
10.1161/hs0302.103619
10.1074/jbc.M509278200
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12883-025-04235-z
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2377
EndPage 11
ExternalDocumentID oai_doaj_org_article_154cc4939fbf4e4a988caeb81b84a1d4
PMC12096771
A840873036
40399867
10_1186_s12883_025_04235_z
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: This study was supported by The National Natural Science Foundation of China
  grantid: NO:82160244
– fundername: Yunnan Provincial Natural Science Foundation project
  grantid: NO: 202001BA070001-156
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABIVO
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
M1P
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7TK
7XB
8FK
AZQEC
DWQXO
K9.
M48
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c517t-9cf9da940c50205721339f4555b93da6cb5f97772efd8965bfe4f1140696b72d3
IEDL.DBID 7X7
ISSN 1471-2377
IngestDate Wed Aug 27 01:26:25 EDT 2025
Thu Aug 21 18:30:12 EDT 2025
Fri Jul 11 17:25:00 EDT 2025
Fri Jul 25 09:29:19 EDT 2025
Tue Jun 17 21:56:12 EDT 2025
Tue Jun 10 20:53:52 EDT 2025
Sun May 25 01:41:17 EDT 2025
Sun Jul 06 05:02:31 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Single-nucleotide polymorphisms
Ischemic stroke
Genetic susceptibility
ATF3
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c517t-9cf9da940c50205721339f4555b93da6cb5f97772efd8965bfe4f1140696b72d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-0220-1493
0009-0001-7528-1156
0000-0002-2550-3822
0000-0002-6336-7673
OpenAccessLink https://www.proquest.com/docview/3216559968?pq-origsite=%requestingapplication%
PMID 40399867
PQID 3216559968
PQPubID 44772
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_154cc4939fbf4e4a988caeb81b84a1d4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12096771
proquest_miscellaneous_3206591167
proquest_journals_3216559968
gale_infotracmisc_A840873036
gale_infotracacademiconefile_A840873036
pubmed_primary_40399867
crossref_primary_10_1186_s12883_025_04235_z
PublicationCentury 2000
PublicationDate 2025-05-21
PublicationDateYYYYMMDD 2025-05-21
PublicationDate_xml – month: 05
  year: 2025
  text: 2025-05-21
  day: 21
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC neurology
PublicationTitleAlternate BMC Neurol
PublicationYear 2025
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References MG Hartman (4235_CR17) 2004; 24
Y Zhao (4235_CR3) 2023; 18
T Hai (4235_CR8) 1999; 7
A Guzik (4235_CR5) 2017; 23
4235_CR11
N Kalfa (4235_CR10) 2008; 180
4235_CR20
Y Tang (4235_CR21) 2006; 21
CD Maida (4235_CR4) 2020; 21
A Ekkert (4235_CR6) 2021; 13
S Bak (4235_CR15) 2002; 33
CY Huang (4235_CR22) 2015; 51
Q Ma (4235_CR2) 2021; 6
A Beleza-Meireles (4235_CR9) 2008; 158
D Lu (4235_CR18) 2006; 281
S Wu (4235_CR1) 2019; 18
SE Humphries (4235_CR12) 2004; 3
H Tsujino (4235_CR19) 2000; 15
K Zhai (4235_CR23) 2017; 96
4235_CR13
4235_CR7
4235_CR14
B Wang (4235_CR16) 2022; 100
References_xml – volume: 6
  start-page: e897
  year: 2021
  ident: 4235_CR2
  publication-title: Lancet Public Health
  doi: 10.1016/S2468-2667(21)00228-0
– volume: 51
  start-page: 543
  year: 2015
  ident: 4235_CR22
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-014-8710-0
– ident: 4235_CR14
  doi: 10.1007/s12975-022-01121-5
– volume: 23
  start-page: 15
  year: 2017
  ident: 4235_CR5
  publication-title: Continuum (Minneap Minn)
  doi: 10.1212/CON.0000000000000416
– volume: 7
  start-page: 321
  year: 1999
  ident: 4235_CR8
  publication-title: Gene Expr
– volume: 100
  start-page: 1557
  year: 2022
  ident: 4235_CR16
  publication-title: J Mol Med (Berl)
  doi: 10.1007/s00109-022-02263-7
– volume: 21
  start-page: 18
  year: 2006
  ident: 4235_CR21
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2005.06.002
– volume: 3
  start-page: 227
  year: 2004
  ident: 4235_CR12
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(04)00708-2
– volume: 15
  start-page: 170
  year: 2000
  ident: 4235_CR19
  publication-title: Mol Cell Neurosci
  doi: 10.1006/mcne.1999.0814
– volume: 18
  start-page: 259
  year: 2023
  ident: 4235_CR3
  publication-title: Int J Stroke
  doi: 10.1177/17474930221135983
– ident: 4235_CR11
  doi: 10.1016/j.cca.2011.02.011
– ident: 4235_CR13
  doi: 10.1073/pnas.1821979116
– ident: 4235_CR20
  doi: 10.1016/j.neuroscience.2012.06.010
– volume: 180
  start-page: 2183
  year: 2008
  ident: 4235_CR10
  publication-title: J Urol
  doi: 10.1016/j.juro.2008.07.066
– volume: 158
  start-page: 729
  year: 2008
  ident: 4235_CR9
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-07-0793
– volume: 21
  start-page: 6454
  year: 2020
  ident: 4235_CR4
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21186454
– volume: 24
  start-page: 5721
  year: 2004
  ident: 4235_CR17
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.24.13.5721-5732.2004
– ident: 4235_CR7
  doi: 10.1016/S0378-1119(01)00551-0
– volume: 18
  start-page: 394
  year: 2019
  ident: 4235_CR1
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(18)30500-3
– volume: 96
  start-page: e7564
  year: 2017
  ident: 4235_CR23
  publication-title: Med (Baltim)
  doi: 10.1097/MD.0000000000007564
– volume: 13
  start-page: 48
  year: 2021
  ident: 4235_CR6
  publication-title: Genes (Basel)
  doi: 10.3390/genes13010048
– volume: 33
  start-page: 769
  issue: 3
  year: 2002
  ident: 4235_CR15
  publication-title: Stroke
  doi: 10.1161/hs0302.103619
– volume: 281
  start-page: 10473
  year: 2006
  ident: 4235_CR18
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M509278200
SSID ssj0017841
Score 2.3961358
Snippet Genetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the...
Background Genetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the...
BackgroundGenetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the...
Abstract Background Genetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker;...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 216
SubjectTerms Activating transcription factor 3
Activating Transcription Factor 3 - genetics
Aged
Association analysis
ATF3
Blood cell count
Blood pressure
Body mass index
Case-Control Studies
China - epidemiology
Cholesterol
Disease susceptibility
Ethylenediaminetetraacetic acid
Female
Fetuses
Gene loci
Gene polymorphism
Genetic aspects
Genetic factors
Genetic Predisposition to Disease - genetics
Genetic susceptibility
Genetic transcription
Genotype
Haplotypes
Humans
Ischemia
Ischemic stroke
Ischemic Stroke - epidemiology
Ischemic Stroke - genetics
Leukocytes
Low density lipoproteins
Male
Middle Aged
Mutation
Polymorphism, Single Nucleotide - genetics
Population studies
Regression analysis
Risk factors
Single nucleotide polymorphisms
Single-nucleotide polymorphism
Software
Stroke
Stroke (Disease)
Triglycerides
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hHhAXxBtDQYuExIGuGnsf3j2GQlQhFXFopXJa7csiojhVnR7a_nlm1psoFgcuSDll15E9j8yM59tvCHkfpBOJu5Z5MBgmIriUTpwz5WoouLz0XX7fcfJNHZ-Jr-fyfGfUF2LCRnrgUXCHEOJDEIabznciCWe0Di55yLa0cHXMTKAQ8zbFVOkfYDdtc0RGq8OhxqG6DEe3Ig5EsttJGMps_X__J-8EpSlgcicCLR6RhyV1pPPxlh-Te6l_Qu6flOb4U3J3hJM2CraNFgAWnZ8uOL1cXUCNDyJdDr8H6vpIl1DVIi6eDuur1a9Elz39DCn5Af0BGa3r6ff8qiGkA-oGGgtmJkXqb6ijAUIfKyB3mglqn5GzxZfTo2NWZiuwIOt2zUzoTHRGzIKEhFFCHchBxEJK6Q2PTgUvO0gN2yZ1URsFOkuig9pppozybRP5c7LXr_r0ktBYz3yKCj7we1zC9tZz3jV1DCo5GSvycSNqezlSaNhcemhlR8VYUIzNirG3FfmE2tjuRPrr_AUYhS1GYf9lFBX5gLq06KSgsODKWQO4YaS7snMoa3WL0bsi-5Od4FxhuryxBluce7C8qRUStSldkXfbZbwSAWt9Wl3jHmxYY5OrIi9G49k-kphBVqhxRU_MavLM05V--TNTf-NJZ9W29av_IaXX5EGTXUKypt4ne-ur6_QGUqy1f5u96Q9tXSUk
  priority: 102
  providerName: Directory of Open Access Journals
Title Correlations between ATF3 polymorphisms and ischemic stroke in Dali, Yunnan Province, as determined by a case-control study
URI https://www.ncbi.nlm.nih.gov/pubmed/40399867
https://www.proquest.com/docview/3216559968
https://www.proquest.com/docview/3206591167
https://pubmed.ncbi.nlm.nih.gov/PMC12096771
https://doaj.org/article/154cc4939fbf4e4a988caeb81b84a1d4
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxNBEF-0BfFF_DZawwqCD3Zp7vbj7p4kqQ1FaCmlhejLsl9Xg3oXc-mD9Z93ZrOJPQQh3EN279i7mdn5zcfOEPLWSSMCNwWzwDBMeBCpMnDOlMnA4LLS1tHfcXKqji_Fp5mcJYdbl9IqN3ti3Kh969BHfsDzTGF1LFV-WPxk2DUKo6uphcZdsouly5Cri9nW4MowprY5KFOqgy7D1roMG7hiNohkNz1lFGv2_7sz31JN_bTJW3po-pA8SACSjtcUf0TuhOYxuXeSQuRPyO9D7LeRMtxoSsOi44spp4v2O1j68GHn3Y-OmsbTOdi2mB1Pu9Wy_RbovKEfAZjv08-Aa01Dz6LDwYV9ajrqU-ZM8NT-ooY6UIAspbrTWKb2KbmcHl0cHrPUYYE5mRUrVrm68qYSIycBNkqwBjmvaiGltBX3RjkrawCIRR5qX1YKKBdEDRbUSFXKFrnnz8hO0zbhBaE-G9ngFfzgeVzC9MJyXueZdyoY6Qfk_eZT68W6kIaOBkip9JowGgijI2H0zYBMkBrbmVgEO_7RLq90kikN6M85UcGKbS2CMFVZOhMsAPFSmMyLAXmHtNQoqkAwZ9KJA1gwFr3SYzBuywJ1-IDs9WaCiLn-8IYbdBLxTv9lyAF5sx3GOzFtrQntNc7BsDWGugbk-Zp5tq8kRoANSxwpe2zVe-f-SDP_GguA43lnVRTZy_-v6xW5n0dmlyzP9sjOankdXgOEWtlhlJMh2Z0cnZ6dD6MjAq7nky9_AJWKH3Y
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxBtDgUUCcaBWY-_D9gGh0BKltKk4pFI4LftyG0HtEKdCKf-J38iMY4daSNwq-eRdW7s7Mzvz7czOEPLKCs0900logGFC7kCkUs9YKHUEgMsIk9fnHaMjOTzmnyZiskF-t3dhMKyy3RPrjdqVFs_Id1gcScyOJdP3sx8hVo1C72pbQmPFFgd--RMgW_Vufw_o-zqOBx_Hu8OwqSoQWhElizCzeeZ0xntWgKkkAAExluVcCGEy5rS0RuRgFCWxz12aSRit5zmghp7MpElix-C_18h1ULw9BHvJZA3wIvThtRdzUrlTRVjKN8SCsRh9IsKLjvKrawT8qwkuqcJumOYlvTe4Q243BivtrzjsLtnwxT1yY9S45O-TX7tY36OJqKNN2BftjweMzsrvy7MSCDmtziqqC0engKUxGp9Wi3n5zdNpQfcACGzTL2BH64J-rg84rN-muqKuidTxjpol1dSCwg2b0Hpap8V9QI6vZO0fks2iLPxjQl3UM95JeOB_TED3xDCWx5Gz0mvhAvK2XWo1WyXuUDXgSaVaEUYBYVRNGHURkA9IjXVPTLpdvyjnJ6qRYQXWprU8gxGbnHuuszS12hsw_FOuI8cD8gZpqXBrAIJZ3dxwgAFjki3VBzCdJmgzBGSr0xNE2nabW25QzZZSqb8CEJCX62b8EsPkCl-eYx90k6NrLSCPVsyznhLvgS2aYkvaYavOnLstxfS0TjiO96tlkkRP_j-uF-TmcDw6VIf7RwdPya24ZnwRxtEW2VzMz_0zMN8W5nktM5R8vWoh_QPnJ1eV
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlations+between+ATF3+polymorphisms+and+ischemic+stroke+in+Dali%2C+Yunnan+Province%2C+as+determined+by+a+case-control+study&rft.jtitle=BMC+neurology&rft.au=Yang%2C+Yunhui&rft.au=Wang%2C+Pengyu&rft.au=Wang%2C+Min&rft.au=Wang%2C+Guangming&rft.date=2025-05-21&rft.pub=BioMed+Central&rft.eissn=1471-2377&rft.volume=25&rft.spage=1&rft_id=info:doi/10.1186%2Fs12883-025-04235-z
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2377&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2377&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2377&client=summon